Headquartered in Milford, MA Fiscal year ends December NYSE: WAT waters.com
Waters Corporation (NYSE: WAT) is a global life sciences and diagnostics company that develops and manufactures analytical technologies, informatics solutions, and related services. The company operates through four divisions: the Analytical Sciences Division (formerly Waters Division, providing liquid chromatography, mass spectrometry, and chemistry consumables), the Biosciences Division (formerly BD Biosciences, specializing in flow cytometry and cell biology instruments and reagents), the Advanced Diagnostics Division (combining the former BD Diagnostic Solutions business with Waters' Clinical Business Unit, focused on microbiology, molecular diagnostics, and clinical mass spectrometry), and the Materials Sciences Division (formerly TA Division, providing thermal analysis and rheometry instruments). Following its February 2026 acquisition of Becton, Dickinson and Company's Biosciences and Diagnostic Solutions businesses, Waters significantly expanded its addressable market into regulated, high-volume testing environments including diagnostics, infection management, and antimicrobial resistance detection. The company serves pharmaceutical, industrial, academic, government, and clinical customers worldwide with approximately 16,000 employees. Updated
Agilent Technologies has a company-confirmed earnings report dropping after the close on August 26, and every operating lever heading into that date is pointing the same direction. Here is what retirement-focused investors…
Live Updates Monday Wrap-up4:26pm ETThe Vanguard S&P 500 ETF closed at 580.14 Monday, up 1.5% — almost an exact mirror of Friday’s 1.6% decline. ViaSat Goes to the Moon1:21pm ETSatellite communications stock…
Live Updates Ladies and Gentlemen, We Have A New Streak4:49pm ETWhat goes up, must come down. After nine straight days of winning, the S&P 500 finally closed lower on Monday — and…
Monday's top analyst upgrades and downgrades included Applied Materials, Autodesk, Bath & Body Works, BJ’s Wholesale Club, Cenovus Energy, Corning, Doximity, HP, Intercontinental Exchange, Macerich, Matador Resources, Palo Alto Networks, Ross Stores,…
BofA Securities has released its top ideas for the rest of 2021. Here are eight top long ideas and two potential shorts for more aggressive investors.
If there is one former Dow Jones industrial average leader that is in need of serious help, look no further than General Electric.
It's another day that the markets are open, so it is widely assumed that Warren Buffett and his Berkshire Hathaway are out looking for deals to make.
Wednesday was a positive day for the broad U.S. markets. Although earnings season is just starting, there wasn’t enough positive momentum to pull the markets up to start out the week. Crude…
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators and Teva Pharmaceutical.
Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday’s gap-up open. This follows last week’s losses.…
The top analyst upgrades, downgrades and other research calls from Tuesday include Applied Materials, BioCryst, Costco, Generac, Goodyear, Intel, Microsoft and Netflix.
The top analyst upgrades, downgrades and other research calls from Monday include Blue Apron, Broadcom, Charter Communications, CVS Health, Delphi, eBay, Rite Aid and UPS.
The top analyst upgrades, downgrades and other research calls seen on Thursday include Analog Devices, BP, First Data, General Electric, Goodyear, Illinois Tool Works, NRG Energy and Palo Alto Networks.
The top analyst upgrades, downgrades and other research calls on Monday include Energy Transfer Equity, First Solar, L3 Technologies, Regions Financial and Western Digital.
With the markets still at all-time highs last week, it was not at all surprising for us here at 24/7 Wall St. to see insiders selling shares.
Waters Corporation (NYSE: WAT) is a global life sciences and diagnostics company that develops and manufactures analytical technologies, informatics solutions, and related services.
24/7 Wall St.'s 12-month price target for WAT is $493.30, rated Buy. The Wall Street consensus target is $453.26. WAT price prediction →
